MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 79 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $7,145,000 | +56.1% | 2,812,815 | +24.7% | 0.11% | +18.7% |
| Q1 2020 | $4,578,000 | -3.7% | 2,255,118 | +2.4% | 0.09% | +44.4% |
| Q4 2019 | $4,756,000 | +179.6% | 2,202,012 | +99.4% | 0.06% | +152.0% |
| Q3 2019 | $1,701,000 | -59.1% | 1,104,551 | +10.2% | 0.02% | -53.7% |
| Q2 2019 | $4,158,000 | – | 1,001,914 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,042,735 | $14,473,000 | 4.95% |
| VHCP Management III, LLC | 1,258,964 | $3,613,000 | 2.63% |
| Granite Point Capital Management, L.P. | 2,659,367 | $7,632,000 | 1.54% |
| Granite Point Capital Management, L.P. | 1,600,000 | $4,592,000 | 0.93% |
| VHCP Management II, LLC | 743,876 | $2,135,000 | 0.92% |
| Monashee Investment Management LLC | 250,000 | $718,000 | 0.49% |
| 683 Capital Management, LLC | 1,350,000 | $3,875,000 | 0.24% |
| CAXTON CORP | 61,443 | $176,000 | 0.21% |
| Tekla Capital Management LLC | 755,776 | $2,169,000 | 0.09% |
| Fosun International Ltd | 491,997 | $1,378,000 | 0.08% |